In less than a month I'll be traveling to Ireland to attend the Keystone meeting on Vaccinology: A new era in immune-driven vaccine design. #KSVaccines26 Really excited to get updated on novel vaccine strategies for infectious disease and oncology. keysym.us/KSVaccines26

Our editor @irismarchal.bsky.social will be attending @keystoneSymposia.bsky.social #Vaccinology : A New Era in #VaccineDesign, this May in Killarney! Join her in discovering emerging research from leaders in the field. keysym.us/KSVaccines26 #KSVaccines26 www.keystonesymposia.org/conferences/...

A new @natbiotech.nature.com Perspective outlines the key algorithms and foundational building blocks driving agentic AI, and discusses biomedical applications, design considerations, and the challenges ahead in making agentic AI deployable at scale in biomedicine. www.nature.com/articles/s41...

Our perspectives piece on Agentic AI for biomedical research has been published in Nature Biotechnology www.nature.com/articles/s41... #agenticAI #artificialintelligence #agents

Engineered cellular immunotherapies for autoimmunity are advancing fast, with many now in clinical trials. This @natbiotech.nature.com Review breaks down what emerging data reveal — and where the field is heading next. www.nature.com/articles/s41...

A new Review in @natbiotech.nature.com presents a vision for engineering synthetic kidneys inspired by natural development. A promising step toward future renal replacement therapies. www.nature.com/articles/s41...

A new review from the Doudna Lab lab on tissue-targeted in vivo delivery of gene editors: https://www.nature.com/articles/s41587-025-02945-w #CRISPR #delivery

RNA structures are hard to solve, but experimental and computational approaches are evolving. This new Perspective in @natbiotech.nature.com shows how their interplay will be the driving force to help the field forward. www.nature.com/articles/s41...

How do you detect transgenes in genome-edited crops? We tested several methods and report our findings in 2 back-to-back papers: onlinelibrary.wiley.com/doi/10.1111/... rdcu.be/eLgUi

The COP16 decision established a multilateral mechanism for digital sequence information benefit-sharing. DSI researchers assess what has been accomplished so far and identify remaining challenges go.nature.com/4nBE4t8 rdcu.be/eJnid

Redefining druggable targets with artificial intelligence - @wcmenglanderipm.bsky.social @aihealthmit.bsky.social go.nature.com/4fHNMYi

How can we engineer B cells to treat diseases? Read about the latest developments of this exciting field in this new Review out now in @natbiotech.nature.com www.nature.com/articles/s41...

Can senolytics reverse or slow aging? Table of companies pursuing this goal. So far the results are questionable. @natbiotech.nature.com www.nature.com/articles/s41...

Gene regulatory networks are crucial for understanding complex gene regulation in plants and could help improve crops for more sustainable and climate-resilient agriculture. Read about it in this Review out now in @natbiotech.nature.com www.nature.com/articles/s41...

This Review presents a classification system of hybrid engineered biological systems to support researchers in making design choices, out now in @natbiotech.nature.com www.nature.com/articles/s41...

Base editors model mitochondrial disease #NBTNV - @mikrobenjaeger.bsky.social go.nature.com/45O9PJM

Anatomy of the 23andMe fall and implications for consumer genomics go.nature.com/3Hf6sBE

Overcoming key hurdles for the development of next-generation anaerobic cultivation methods could have major impacts on microbial community research and applications. Read how in this new Perspective in @natbiotech.nature.com www.nature.com/articles/s41...

A call for built-in biosecurity safeguards for generative AI tools go.nature.com/3GIpTlR

Here we share thoughts on next-gen cultivation: rdcu.be/ejPSb. Hope it helps 😄 Was fun to write with great colleagues @lisamaierlab.bsky.social @jselkrig.bsky.social @baerboletta.bsky.social @typaslab.bsky.social @mmmicrobiomelab.bsky.social @leibniz-dsmz.bsky.social @westermannlab.bsky.social

1/ We need new ways of producing foods and fuels to minimise our impact on our planet. Our new paper now in @natbiotech.nature.com examines whether microbes hold the key to producing foods and fuels in the future Open access: rdcu.be/eiIUu nature.com/articles/s41...

The development of therapeutic cancer vaccines is seeing exciting progress recently. Curious how researchers are dealing with challenges to translate new technologies to the clinic? @natbiotech.nature.com asked experts for an update. www.nature.com/articles/s41...

Cell therapies are transforming our ability to treat cancer but are out of reach for many patients. @natbiotech.nature.com asked experts to share their insights into pressing challenges and promising strategies to make these therapies more broadly accessible www.nature.com/articles/s41...

A look back at what vaccines have done.

Proud of our new perspective describing the role of mathematical biology for immunotherapy www.nature.com/articles/s41... @natbiotech.nature.com

This month, we've focused on recent developments as well as challenges in cancer immunotherapy, including cancer vaccines, immune checkpoint inhibitors, and CAR-engineered cells. Please read more👇

Innate immune cells are promising candidates for cancer immunotherapy and various engineering strategies can be employed to set them up for success. Read about is in this Review in @natbiotech.nature.com and don't forget to check out our full Focus Issue! www.nature.com/articles/s41...

🔥New Night Science paper!! Discovery happens when your initial plans fall apart but it requires you to have a particular mindset: it's not extraverted, orderly, neurotic or agreeable that's the most important – discovery requires an OPENNESS to new ideas and unexpected insights.

Shares of US drugmakers fell after reports that @fda.gov top vaccine official, Peter Marks, had been forced to resign, as the Trump administration undertakes an overhaul of federal health agencies #NBTNewsBeat www.reuters.com/business/hea...

Check out the state of the field of engineered bacteria for cancer therapy in this Comment in @naturebiotech.bsky.social www.nature.com/articles/s41...

Modulating induced proximity at the cell surface is a powerful engineering strategy that can find diverse applications in basic and translational science. Curious to learn about emerging modalities in this space? Read this review out now in @naturebiotech.bsky.social www.nature.com/articles/s41...

Nanopore technology might be able to sequence proteins soon! Read about the road ahead in this exciting Perspective rdcu.be/edWPi in @naturebiotech.bsky.social

The program of the CiRT2025 meeting is out: meeting2025.cirt-net.org/program.html. I will be sharing my top 10 tips on publishing with @naturebiotech.bsky.social. See you there?

Our article is now out in Nature Biotechnology. Here we outline challenges for developing broad-based mucosal vaccines for respiratory viruses. Check it out! Congrats to Junghwa and Jordan from my lab and to other co-authors! www.nature.com/articles/s41...

Natural and engineered Cas12 and TnpB variants offer diverse applications in genome editing and diagnostics - read all about it in this Review in @naturebiotech.bsky.social www.nature.com/articles/s41...